+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 4Years - 8Years
All Genders
ID03952299

Study of Oral vs. Transdermal Oxybutynin for Reducing Bladder Pain and Urgency After Surgery in Children Ages 4 to 8

Led by University of California, Davis · Updated on 2026-01-29

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether transdermal oxybutynin is better than oral oxybutynin at reducing bladder pain and urgency after bladder surgery in children aged 4 to 8 years. Bladder pain and urgency are common after surgery, and current treatments include narcotics, anti-inflammatory drugs, and oral oxybutynin, which has limited effectiveness due to how the body processes it. This study focuses on comparing these two delivery methods to find the best way to manage pain and urgency after surgery.

CONDITIONS

Brief Title

Oxybutynin for Post-surgical Bladder Pain and Urgency

Research Team

A

Anjali Vij, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here